Quantessence Capital LLC Viatris Inc Transaction History
Quantessence Capital LLC
- $316 Billion
- Q3 2025
A detailed history of Quantessence Capital LLC transactions in Viatris Inc stock. As of the latest transaction made, Quantessence Capital LLC holds 17,858 shares of VTRS stock, worth $191,437. This represents 0.06% of its overall portfolio holdings.
Number of Shares
17,858
Previous 187,869
90.49%
Holding current value
$191,437
Previous $1.68 Billion
89.46%
% of portfolio
0.06%
Previous 0.49%
Shares
2 transactions
Others Institutions Holding VTRS
# of Institutions
1,133Shares Held
966MCall Options Held
7.74MPut Options Held
2.47M-
Vanguard Group Inc Valley Forge, PA140MShares$1.5 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$993 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD84.1MShares$901 Million0.09% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az69.3MShares$743 Million3.68% of portfolio
-
State Street Corp Boston, MA55.7MShares$597 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...